全球體內毒理學市場規模、佔有率、趨勢和成長分析報告（2026-2034）

預計體內毒性測試市場將從 2025 年的 64.1 億美元成長到 2034 年的 108.9 億美元，2026 年至 2034 年的複合年成長率為 6.07%。

由於對藥物化合物、化學物質和醫療產品的安全性和毒性評估需求日益成長，全球體內毒性測試市場正在擴張。體內毒性測試是指在臨床試驗和商業化之前，對物質進行體內測試，以評估其潛在的健康風險。這些測試對於藥物研發和監管核准流程至關重要。

製藥和生物技術公司在毒性測試方面投入大量資金，以確保新藥和治療產品的安全性。活性化的研究活動和日益嚴格的安全評估監管要求推動了體內毒性測試的需求。受託研究機構（CRO）也發揮著至關重要的作用，提供專業的毒性測試服務。

未來，隨著全球藥物開發平臺的擴展，市場預計將持續成長。毒性測試的效率將透過先進技術的整合和測試方法的改進而提高。儘管出現了其他測試方法，但體內毒性測試仍將是臨床前研究和安全性評估的關鍵要素。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

• 市場譜系展望
• 滲透率和成長前景分析
• 價值鏈分析
• 法律規範
  • 標準與合規性
  • 監管影響分析
• 市場動態
  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 市場挑戰
• 波特五力分析
• PESTLE分析

第4章 全球生物毒理學市場：依產品分類

• 市場分析、洞察與預測
• 裝置
• 耗材（試劑、試劑盒、動物模型）

第5章 全球體內毒理學市場：依測試類型分類

• 市場分析、洞察與預測
• 急性
• 亞急性
• 亞慢性
• 慢性試驗類型

第6章：全球體內毒理學市場：依實驗室分類

• 市場分析、洞察與預測
• 外包測試設施
• 內部測試設施

第7章 全球體內毒理學市場：依毒性終點分類

• 市場分析、洞察與預測
• 免疫毒性
• 全身毒性
• 致癌性
• 基因毒性
• 發育和生殖毒性
• 其他毒性終點

第8章 全球生物毒理學市場：依最終用戶分類

• 市場分析、洞察與預測
• 學術研究機構
• 製藥和生物技術公司
• 受託研究機構
• 其他

第9章 全球生物毒理學市場：依地區分類

• 區域分析
• 北美市場分析、洞察與預測
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲市場分析、洞察與預測
  • 英國
  • 法國
  • 德國
  • 義大利
  • 俄羅斯
  • 其他歐洲國家
• 亞太市場分析、洞察與預測
  • 印度
  • 日本
  • 韓國
  • 澳洲
  • 東南亞
  • 其他亞太國家
• 拉丁美洲市場分析、洞察與預測
  • 巴西
  • 阿根廷
  • 秘魯
  • 智利
  • 其他拉丁美洲國家
• 中東和非洲市場分析、洞察與預測
  • 沙烏地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中東和非洲國家

第10章 競爭格局

• 最新趨勢
• 公司分類
• 供應鏈和銷售管道合作夥伴（根據現有資訊）
• 市場佔有率和市場定位分析（基於現有資訊）
• 供應商情況（基於現有資訊）
• 策略規劃

第11章：公司簡介

• 主要公司的市佔率分析
• 公司簡介
  • Charles River Laboratories
  • The Jackson Laboratory
  • Envigo
  • Taconic Biosciences Inc
  • GenOway
  • Thermo Fisher Scientific
  • Danaher Corporation
  • Waters Corporation
  • Agilent Technologies
  • Shimadzu Corporation
  • Bruker Corporation

The In Vivo Toxicology Market size is expected to reach USD 10.89 Billion in 2034 from USD 6.41 Billion (2025) growing at a CAGR of 6.07% during 2026-2034.

The global in vivo toxicology market is expanding due to the growing need to evaluate the safety and toxicity of pharmaceutical compounds, chemicals, and medical products. In vivo toxicology studies involve testing substances in living organisms to assess potential health risks before clinical trials or commercial use. These studies are essential in drug development and regulatory approval processes.

Pharmaceutical and biotechnology companies are investing heavily in toxicology testing to ensure the safety of new drugs and therapeutic products. Increasing research activities and strict regulatory requirements for safety evaluation are driving demand for in vivo toxicology studies. Contract research organizations are also playing a key role by providing specialized toxicology testing services.

In the future, the market is expected to grow as drug development pipelines expand globally. The integration of advanced technologies and improved testing methodologies will enhance the efficiency of toxicology studies. While alternative testing approaches are emerging, in vivo toxicology will remain an important component of preclinical research and safety evaluation.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product

• Instruments
• Consumables (Reagents & Kits, Animal Models)

By Test Type

• Acute
• Sub-Acute
• Sub-Chronic
• Chronic Test Type

By Testing Facility

• Outsourced Testing Facility
• In-House Testing Facility

By Toxicity End Point

• Immunotoxicity
• Systemic Toxicity
• Carcinogenicity
• Genotoxicity
• Development And Reproductive Toxicity
• Other Toxicity End Point

By End User

• Academic And Research Institutes
• Pharmaceutical & Biotechnology Companies
• Contract Research Organizations
• Others

COMPANIES PROFILED

• Charles River Laboratories, The Jackson Laboratory, Envigo, Taconic Biosciences Inc, genOway, Thermo Fisher Scientific, Danaher Corporation, Waters Corporation, Agilent Technologies, Shimadzu Corporation, Bruker Corporation
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL IN VIVO TOXICOLOGY MARKET: BY PRODUCT 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Product
• 4.2. Instruments Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Consumables (Reagents & Kits, Animal Models) Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL IN VIVO TOXICOLOGY MARKET: BY TEST TYPE 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Test Type
• 5.2. Acute Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Sub-Acute Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Sub-Chronic Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Chronic Test Type Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL IN VIVO TOXICOLOGY MARKET: BY TESTING FACILITY 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Testing Facility
• 6.2. Outsourced Testing Facility Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. In-House Testing Facility Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL IN VIVO TOXICOLOGY MARKET: BY TOXICITY END POINT 2022-2034 (USD MN)

• 7.1. Market Analysis, Insights and Forecast Toxicity End Point
• 7.2. Immunotoxicity Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.3. Systemic Toxicity Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.4. Carcinogenicity Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.5. Genotoxicity Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.6. Development And Reproductive Toxicity Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.7. Other Toxicity End Point Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL IN VIVO TOXICOLOGY MARKET: BY END USER 2022-2034 (USD MN)

• 8.1. Market Analysis, Insights and Forecast End User
• 8.2. Academic And Research Institutes Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 8.3. Pharmaceutical & Biotechnology Companies Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 8.4. Contract Research Organizations Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 8.5. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 9. GLOBAL IN VIVO TOXICOLOGY MARKET: BY REGION 2022-2034(USD MN)

• 9.1. Regional Outlook
• 9.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.2.1 By Product
  • 9.2.2 By Test Type
  • 9.2.3 By Testing Facility
  • 9.2.4 By Toxicity End Point
  • 9.2.5 By End User
  • 9.2.6 United States
  • 9.2.7 Canada
  • 9.2.8 Mexico
• 9.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.3.1 By Product
  • 9.3.2 By Test Type
  • 9.3.3 By Testing Facility
  • 9.3.4 By Toxicity End Point
  • 9.3.5 By End User
  • 9.3.6 United Kingdom
  • 9.3.7 France
  • 9.3.8 Germany
  • 9.3.9 Italy
  • 9.3.10 Russia
  • 9.3.11 Rest Of Europe
• 9.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.4.1 By Product
  • 9.4.2 By Test Type
  • 9.4.3 By Testing Facility
  • 9.4.4 By Toxicity End Point
  • 9.4.5 By End User
  • 9.4.6 India
  • 9.4.7 Japan
  • 9.4.8 South Korea
  • 9.4.9 Australia
  • 9.4.10 South East Asia
  • 9.4.11 Rest Of Asia Pacific
• 9.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.5.1 By Product
  • 9.5.2 By Test Type
  • 9.5.3 By Testing Facility
  • 9.5.4 By Toxicity End Point
  • 9.5.5 By End User
  • 9.5.6 Brazil
  • 9.5.7 Argentina
  • 9.5.8 Peru
  • 9.5.9 Chile
  • 9.5.10 South East Asia
  • 9.5.11 Rest of Latin America
• 9.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.6.1 By Product
  • 9.6.2 By Test Type
  • 9.6.3 By Testing Facility
  • 9.6.4 By Toxicity End Point
  • 9.6.5 By End User
  • 9.6.6 Saudi Arabia
  • 9.6.7 UAE
  • 9.6.8 Israel
  • 9.6.9 South Africa
  • 9.6.10 Rest of the Middle East And Africa

Chapter 10. COMPETITIVE LANDSCAPE

• 10.1. Recent Developments
• 10.2. Company Categorization
• 10.3. Supply Chain & Channel Partners (based on availability)
• 10.4. Market Share & Positioning Analysis (based on availability)
• 10.5. Vendor Landscape (based on availability)
• 10.6. Strategy Mapping

Chapter 11. COMPANY PROFILES OF GLOBAL IN VIVO TOXICOLOGY INDUSTRY

• 11.1. Top Companies Market Share Analysis
• 11.2. Company Profiles
  • 11.2.1 Charles River Laboratories
  • 11.2.2 The Jackson Laboratory
  • 11.2.3 Envigo
  • 11.2.4 Taconic Biosciences Inc
  • 11.2.5 GenOway
  • 11.2.6 Thermo Fisher Scientific
  • 11.2.7 Danaher Corporation
  • 11.2.8 Waters Corporation
  • 11.2.9 Agilent Technologies
  • 11.2.10 Shimadzu Corporation
  • 11.2.11 Bruker Corporation